Erlotinib vs Ondansetron

Erlotinib vs Ondansetron: Overview

This comparison examines the pharmacological differences between Erlotinib and Ondansetron.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Ondansetron: Selective 5-HT3 receptor antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Ondansetron — 3-5 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Ondansetron — C18H19N3O.

Molecular Weight: Erlotinib — 393.4380 g/mol; Ondansetron — 293.3660 g/mol.

Type: Erlotinib — Small molecule; Ondansetron — Small molecule.